North America Allergy Immunotherapies Market

Market Introduction

Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies. Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy primary therapeutic goals include reducing symptoms, reducing symptomatic medication use, and improving allergy-related quality of life.

Market Overview and Dynamics

The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3 % during the forecast period. This can be attributed to the growing developments in the healthcare sector due to R&D activities in this industry. The increasing initiatives taken by various research institutes and organizations for improving medical facilities and services are further leading to market growth. The growing number of health disorders and rising demand for improved treatment and preventive measures has led to technological advancements in the medical industry.

Key Market Segments

Based on Treatment, the SCIT segment held a larger share of the North America allergy immunotherapies market in 2019. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. Based on allergy type, the allergic rhinitis segment held the greatest share of the market in 2019, and is anticipated to register the highest CAGR in the market during forecast period.

Based on distribution channel, the hospital pharmacy settings segment held the largest share of the  North America allergy immunotherapies market in 2019, and is expected to grow at the fastest CAGR during the forecast period.

Major Sources and Companies Listed

Some of the major primary and secondary sources for the North America allergy immunotherapies market included in the report are American Academy of Allergy, Asthma & Immunology, Celsion Corporation, the US Food and Drug Administration (FDA) and World Allergy Organization (WAO).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of the North America allergy immunotherapy market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America immunotherapy market.

NORTH AMERICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION

North America Allergy Immunotherapies Market – By Treatment

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

North America Allergy Immunotherapies Market – By Allergy Type

• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others

North America Allergy Immunotherapies Market – By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

North America Allergy Immunotherapies Market – By Geography

• United Sates
• Mexico
• Canada

Company Profiles

• Johnson and Johnson Services, Inc.
• ALK Abello A/S 
• Aimmune Therapeutics
• Anergis
• Circassia 

North America Allergy Immunotherapies Market Strategic Insights

North America Allergy Immunotherapies Market Segmentation Analysis

North America Allergy Immunotherapies Market Report Highlights

North America Allergy Immunotherapies Report Scope

North America Allergy Immunotherapies Market Country and Regional Insights